2nd Quarter - Report

BECTON, DICKINSON AND COMPANY for BECTON DICKINSON AND COMPANY

Firm
Client
Income
—
Expenses
$140,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 759, Food and Drug Administration Globalization Act of 2009, Issues related to import safety S.301, Physician Payments Sunshine Act of 2009, Issues related to medical device company/physician relationship Issues related to FDA regulation of diagnostic tests Issues related to pandemic flu and H1N1 vaccine Issues related to healthcare reform (H.R. 3200) and healthcare-associated infections Issues related to healthcare reform (H.R. 3200) and diagnostic payment reform Issues related to safe injection practices

LobbyistCovered position, as disclosed
ANTHONY LAKAVAGE —
PAUL SELTMAN —
ELIZABETH WOODY New —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3200 (111th), H.R. 759 (111th), S. 301 (111th)

Medicare/Medicaid MMM

Proposed legislation related to sharps and safe needle disposal Issues related to diagnostic payment reform proposal

LobbyistCovered position, as disclosed
PAUL SELTMAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

H.R.2346, Supplemental Appropriations Act, 2009, Issues relating to H1N1 vaccine and pandemic flu S.1054, Supplemental Appropriations Act, 2009, Issues relating to H1N1 vaccine and pandemic flu

LobbyistCovered position, as disclosed
ANTHONY LAKAVAGE —
PAUL SELTMAN —
ELIZABETH WOODY New —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1054 (111th), H.R. 2346 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.